Memantine binding to a superficial site on NMDA receptors contributes to partial trapping
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Although many nervous system disorders are associated with N‐methyl‐d‐aspartate (NMDA) receptor overactivation, pharmacological inhibition of NMDA receptors has typically demonstrated limited clinical value due to debilitating psychotomimetic side‐effects. Memantine, however, induces far fewer behavioural side‐effects than other NMDA receptor channel blockers such as ketamine, and slows the progressive cognitive decline associated with Alzheimer's disease. Memantine and ketamine inhibit NMDA receptors with similar affinity and kinetics. A prominent mechanistic difference between memantine and ketamine is the degree to which they are ‘trapped’ within the closed channel of NMDA receptors following removal of agonist: ketamine becomes trapped in nearly all NMDA receptors to which it was bound before agonist removal, whereas some bound memantine molecules dissociate after agonist removal, a phenomenon called partial trapping. Here we investigated the mechanism underlying partial trapping of memantine by recombinant NR1/2A NMDA receptors. We found that memantine dissociation from NR1/2A receptors after agonist removal (the process that results in partial trapping) followed an exponential time course with τ= 0.79 ± 0.32 s. Neither membrane voltage depolarization nor maintained presence of memantine after agonist removal affected partial trapping, suggesting that partial trapping does not result from memantine escape through open channels. We tested the hypothesis that partial trapping results from binding of memantine to two sites, a superficial ‘non‐trapping’ site and a deep ‘trapping’ site, which cannot be occupied simultaneously. This hypothesis was supported by the lack of ketamine binding to the superficial site, the voltage dependence of partial trapping, and the effect on partial trapping of a mutation near the deep site. The superficial binding site for memantine may, by causing partial trapping, contribute to memantine's unique therapeutic utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Glutamate Receptor Ion Channels
Dingledine, R., Borges, K., Bowie, D., & Traynelis, S. F. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01394-2 · Cited by 3,554 · cited 5×
“…of NMDA receptors by memantine, Mg2+o , and other channel blockers is strongly affected by mutation of the ‘N-site’ asparagines in the M2 reentrant loops of NMDA receptors (Burnashev et al. 1992; Kuner & Schoepfer, 1996; Wollmuth et al. 1996, 1998; Dingledine et al. 1999; Kashiwagi et al. 2002).”
BackgroundInfluentialKrystal, J. H., D'Souza, D. C., Mathalon, D., Perry, E., Belger, A., & Hoffman, R. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1582-z · Cited by 530
Mg2+Imparts NMDA Receptor Subtype Selectivity to the Alzheimer's Drug Memantine
Kotermanski, S. E., & Johnson, J. W. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3703-08.2009 · Cited by 271 · cited 1×
“2), which are similar to previously reported values (Parsons et al. 1995; Blanpied et al. 1997; Sobolevsky & Koshelev, 1998; Sobolevsky et al. 1998; Mealing et al. 1999; Kashiwagi et al. 2002; Kotermanski & Johnson, 2009).”
ResultSelf-citationMultiple Structural Elements Determine Subunit Specificity of Mg2+Block in NMDA Receptor Channels
Kuner, T., & Schoepfer, R. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-11-03549.1996 · Cited by 235 · cited 1×
“…of NMDA receptors by memantine, Mg2+o , and other channel blockers is strongly affected by mutation of the ‘N-site’ asparagines in the M2 reentrant loops of NMDA receptors (Burnashev et al. 1992; Kuner & Schoepfer, 1996; Wollmuth et al. 1996, 1998; Dingledine et al. 1999; Kashiwagi et al. 2002).”
Background
Cited by
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568
“However, memantine differs mechanistically from potent first generation channel blockers in its lower affinity, faster dissociation kinetics, the distinct mechanism by which it becomes trapped in the channel (Parsons et al., 1999; Danysz et al., 2000; Chen and Lipton, 2006; Kotermanski et al., 2009; Kotermanski and Jo…”
BackgroundKetamine and Ketamine Metabolite Pharmacology: Insights into Therapeutic Mechanisms
Zanos, P., Moaddel, R., Morris, P. J., Riggs, L. M., Highland, J. N., Georgiou, P., Pereira, E. F. R., Albuquerque, E. X., Thomas, C. J., Zarate, C. A., et al. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.015198 · Cited by 1,260
“ketamine is likely not the result of higher affinity of ketamine to bind to the GluN2C-NMDARs per se, but may be due to differential capacity for Mg binding, or interactions between the drug and Mg within the channel (Kotermanski and Johnson, 2009; Kotermanski et al., 2009).”
BackgroundStructure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Hansen, K. B., Wollmuth, L. P., Bowie, D., Furukawa, H., Menniti, F. S., Sobolevsky, A. I., Swanson, G. T., Swanger, S. A., Greger, I. H., Nakagawa, T., et al. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000131 · Cited by 686
Structure, function, and allosteric modulation of NMDA receptors
Hansen, K. B., Yi, F., Perszyk, R. E., Furukawa, H., Wollmuth, L. P., Gibb, A. J., & Traynelis, S. F. (2018) · Journal of General Physiology · doi:10.1085/jgp.201812032 · Cited by 573
Ketamine: NMDA Receptors and Beyond
Zorumski, C. F., Izumi, Y., & Mennerick, S. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1547-16.2016 · Cited by 254
Sartori, S. B., & Singewald, N. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107402 · Cited by 236
Gideons, E. S., Kavalali, E. T., & Monteggia, L. M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1323920111 · Cited by 232
“The clinical findings demonstrating differences between ketamine and memantine in triggering rapid antidepressant responses are rather surprising, because both drugs are noncompetitive NMDAR antagonists that block the receptor when it is in an open configuration (16, 20).”
BackgroundEffects of a ketamine metabolite on synaptic NMDAR function
Suzuki, K., Nosyreva, E., Hunt, K. W., Kavalali, E. T., & Monteggia, L. M. (2017) · Nature · doi:10.1038/nature22084 · Cited by 180
Sanacora, G., & Schatzberg, A. F. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.261 · Cited by 160
Patrizi, A., Picard, N., Simon, A. J., Gunner, G., Centofante, E., Andrews, N. A., & Fagiolini, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.08.018 · Cited by 100
“It is noteworthy that there are several differences in the way memantine and ketamine interact with NMDAR, including their ability to change glutamate binding at rest (69), the trapping properties of the drugs (70), and their unique effects on synaptic and extrasynaptic receptors (71).”
Fedele, L., Newcombe, J., Topf, M., Gibb, A., Harvey, R. J., & Smart, T. G. (2018) · Nature Communications · doi:10.1038/s41467-018-02927-4 · Cited by 82
Picard, N., Takesian, A. E., Fagiolini, M., & Hensch, T. K. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0341-9 · Cited by 71
Zorumski, C. F., Nagele, P., Mennerick, S., & Conway, C. R. (2015) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2015.00172 · Cited by 57
“In contrast, memantine, another NMDAR channel blocker also binds a superficial site within the channel, perhaps accounting for differences from ketamine (63).”
BackgroundNMDA receptor antagonism: escalation of aggressive behavior in alcohol-drinking mice
Newman, E. L., Chu, A., Bahamón, B., Takahashi, A., DeBold, J. F., & Miczek, K. A. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2734-9 · Cited by 46
“Memantine and neramexane are unique uncompetitive NMDAR antagonists with low receptor affinities, enabling ‘partial trapping’—a tendency to unblock some receptors between depolarizations (Blanpied et al. 1997; Kotermanski et al. 2009).”
Ingram, R., Kang, H., Lightman, S., Jane, D. E., Bortolotto, Z. A., Collingridge, G. L., Lodge, D., & Volianskis, A. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.06.008 · Cited by 36
“The competition with Mg2+ explains the lower IC50 values for the blockade of GluN2C/2D than for GluN2A/2B containing NMDA receptors by ketamine and other NMDAR channel blockers (Dravid et al., 2007; Kotermanski and Johnson, 2009; Kotermanski et al., 2009).”
Metadata
- Authors
- Kotermanski, S. E., Wood, J. T., & Johnson, J. W.
- Venue
- The Journal of Physiology
- Publisher
- Wiley
- Published
- 2009-09-29
- Volume
- 587
- Issue
- 19
- Pages
- 4589-4604
- ISSN
- 0022-3751 (ISSN-L)
- 1469-7793
- OpenAlex
- W2102686440
- Cited by
- 92
- References
- 4
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.